ArrowMark Colorado Holdings’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-119,684
Closed -$11.6M 324
2022
Q3
$11.6M Sell
119,684
-10,005
-8% -$1.14M 0.14% 133
2022
Q2
$12M Buy
129,689
+63,028
+95% +$8.93M 0.14% 140
2022
Q1
$14.3M Buy
66,661
+2,166
+3% +$506K 0.13% 148
2021
Q4
$22.1M Buy
64,495
+1,181
+2% +$456K 0.18% 120
2021
Q3
$22.6M Buy
63,314
+6,379
+11% +$2.38M 0.18% 120
2021
Q2
$12.8M Buy
56,935
+3,200
+6% +$1.19M 0.1% 173
2021
Q1
$27M Buy
+53,735
New +$27.6M 0.2% 110

Other funds holding TIL

ArrowMark Colorado Holdings's TIL Position: Q4 2022 in Review

ArrowMark Colorado Holdings sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 119,684 shares — an estimated $11.6M sold.

ArrowMark Colorado Holdings first reported a position in TIL in Q1 2021 and held it in 7 quarters. The position peaked at $27M in Q1 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • ArrowMark Colorado Holdings reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 119,684 Instil Bio shares in Q4 2022, an estimated $11.6M.
  • ArrowMark Colorado Holdings first reported a position in Instil Bio in Q1 2021 and held it in 7 quarters.
  • ArrowMark Colorado Holdings's Instil Bio position peaked at $27M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.